Bull, base and bear scenarios, opening on what this business has actually done — its realised growth rates and its own P/E range, not round numbers we chose.
Projections are part of Pro
Set the growth, margin and multiple yourself and watch the price land where your assumptions put it — for Kenvue Inc. and every other company we cover.
Try it first on NVDA, AAPL, META, NKE or CAKE, where it is open to everyone.
$19.31-1.3%Oct 30 close
Figures through September 27, 2026, from the 10-Q filed October 30, 2026
Kenvue sells nonprescription medicines to shoppers through pharmacies and retailers, alongside skin care, mouthwash, baby care and wound-care products.